Evidence suggests altering levels of endocan in patients with ARDS, pneumonia, and pulmonary thromboembolism showing that endocan is involved in the vascular damage molecular mechanisms in the respiratory system.11, 15. The gene discussed is ESM1; the disease is pneumonia.